{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T20:11:41Z","timestamp":1769631101699,"version":"3.49.0"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,8,1]]},"DOI":"10.1093\/jac\/dkm145","type":"journal-article","created":{"date-parts":[[2007,6,12]],"date-time":"2007-06-12T02:32:15Z","timestamp":1181615535000},"page":"424-428","source":"Crossref","is-referenced-by-count":69,"title":["Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005"],"prefix":"10.1093","volume":"60","author":[{"given":"Margarete Borg-von","family":"Zepelin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Kunz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"R\u00fcchel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Utz","family":"Reichard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Weig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Gro\u00df","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2007,6,11]]},"reference":[{"key":"key\n\t\t\t\t20171012174441_DKM145C1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: a persistent public health problem","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20171012174441_DKM145C2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/421946","article-title":"Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study","volume":"39","author":"Wisplinghoff","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171012174441_DKM145C3","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1086\/342300","article-title":"Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989\u20131999","volume":"35","author":"Trick","year":"2002","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171012174441_DKM145C4","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1086\/514731","article-title":"Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)","volume":"28","author":"Viscoli","year":"1999","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171012174441_DKM145C5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10096-004-1103-y","article-title":"Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study","volume":"23","author":"Tortorano","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20171012174441_DKM145C6","volume-title":"Atlas of Clinical Fungi, Second Edition","author":"de Hoog","year":"2000"},{"key":"key\n\t\t\t\t20171012174441_DKM145C7","volume-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts\u2014Second Edition: Approved Standard M27-A2","author":"National Committee for Clinical Laboratory Standards","year":"2002"},{"key":"key\n\t\t\t\t20171012174441_DKM145C8","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1128\/JCM.42.8.3475-3482.2004","article-title":"Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species","volume":"42","author":"Odds","year":"2004","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171012174441_DKM145C9","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1128\/JCM.44.3.819-826.2006","article-title":"Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints","volume":"44","author":"Pfaller","year":"2006","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171012174441_DKM145C10","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1128\/JCM.38.9.3457-3459.2000","article-title":"Quality control limits for broth microdilution susceptibility tests of ten antifungal agents","volume":"38","author":"Barry","year":"2000","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171012174441_DKM145C11","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1086\/380637","article-title":"Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991\u20132000","volume":"38","author":"Marchetti","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171012174441_DKM145C12","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1128\/JCM.40.3.852-856.2002","article-title":"Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000","volume":"40","author":"Pfaller","year":"2002","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171012174441_DKM145C13","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/jac\/dkh548","article-title":"In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: results from a population-based active surveillance programme, Barcelona, Spain, 2002\u20132003","volume":"55","author":"Cuenca-Estrella","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171012174441_DKM145C14","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s10096-004-1210-9","article-title":"Neonatal candidiasis: analysis of epidemiology, drug susceptibility, and molecular typing of causative isolates","volume":"23","author":"Roilides","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20171012174441_DKM145C15","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1086\/497079","article-title":"Candida kefyr as an emerging pathogen causing nosocomial bloodstream infections in neutropenic leukemia patients","volume":"41","author":"Reuter","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171012174441_DKM145C16","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1128\/AAC.47.3.1068-1071.2003","article-title":"In vitro activities of caspofungin compared with those of fluconazole and itraconazole against 3,959 clinical isolates of Candida spp., including 157 fluconazole-resistant isolates","volume":"47","author":"Pfaller","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171012174441_DKM145C17","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1046\/j.1439-0507.1999.00518.x","article-title":"Itraconazole trough concentrations in antifungal prophylaxis with six different dosing regimens using hydroxypropyl-\u03b2-cyclodextrin oral solution or coated-pellet capsules","volume":"42","author":"Glasmacher","year":"1999","journal-title":"Mycoses"},{"key":"key\n\t\t\t\t20171012174441_DKM145C18","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1128\/AAC.46.11.3518-3521.2002","article-title":"In vitro activities of 5-fluorocytosine against 8,803 clinical isolates of Candida spp.: global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods","volume":"46","author":"Pfaller","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171012174441_DKM145C19","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/jac\/dkf060","article-title":"Antifungal susceptibilities of Candida spp. isolated from blood in Spain and Argentina, 1996\u20131999","volume":"49","author":"Cuenca-Estrella","year":"2002","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/60\/2\/424\/2096976\/dkm145.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T01:54:59Z","timestamp":1587606899000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/60\/2\/424\/711708\/Epidemiology-and-antifungal-susceptibilities-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,11]]},"references-count":19,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2007,6,11]]},"published-print":{"date-parts":[[2007,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkm145","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2007,8]]},"published":{"date-parts":[[2007,6,11]]}}}